| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |